WO2007018744A2 - Biosynthese sans cellule d'acide nucleique - Google Patents

Biosynthese sans cellule d'acide nucleique Download PDF

Info

Publication number
WO2007018744A2
WO2007018744A2 PCT/US2006/023439 US2006023439W WO2007018744A2 WO 2007018744 A2 WO2007018744 A2 WO 2007018744A2 US 2006023439 W US2006023439 W US 2006023439W WO 2007018744 A2 WO2007018744 A2 WO 2007018744A2
Authority
WO
WIPO (PCT)
Prior art keywords
therapeutic
dna
composition according
research
sequence
Prior art date
Application number
PCT/US2006/023439
Other languages
English (en)
Other versions
WO2007018744A3 (fr
Inventor
Yin Chen
Frederic Kendirgi
Frank Vazquez
Malcolm Skolnick
Original Assignee
Cytogenix, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2005/045028 external-priority patent/WO2006063355A2/fr
Application filed by Cytogenix, Inc. filed Critical Cytogenix, Inc.
Publication of WO2007018744A2 publication Critical patent/WO2007018744A2/fr
Publication of WO2007018744A3 publication Critical patent/WO2007018744A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6846—Common amplification features

Abstract

La présente invention concerne un processus permettant de produire un ADN de haute qualité dans un système sans cellule, exempt d'impuretés bactériennes et exempt de manière optimale de séquences codantes pour des gènes bactériens qui peuvent minimiser ou rendre silencieux une expression de gène lorsqu'elle est utilisée pour l'expression à l'intérieur d'une cellule cible. Ce système sans cellule est un procédé rapide qui fournit un produit final hautement fidèle, plus propre convenant pour des applications thérapeutiques avec moins d'efforts et de dépenses et, qui peut être adapté à l'amplification de matrices de type plasmide manquant de séquences de gènes plasmide bactériennes non nécessaires. Ceci permet d'accroître l'efficacité du système et d'accroître l'efficacité du vecteur d'expression de produit final. Ce produit final peut être facilement utilisé comme ADN thérapeutique du fait de la faible incidence des composants de cellule bactérienne et des toxines bactériennes. Cette invention concerne aussi un procédé de production d'ADN pour quelque recherche ou quelque but thérapeutique que ce soit, qui est sensiblement exempt d'impuretés de cellule bactérienne, ainsi qu'une thérapeutique de produit fini comprenant des vaccins ADN.
PCT/US2006/023439 2005-08-03 2006-06-14 Biosynthese sans cellule d'acide nucleique WO2007018744A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US70534805P 2005-08-04 2005-08-04
US60/705,348 2005-08-04
USPCTUS22000/045028 2005-12-12
PCT/US2005/045028 WO2006063355A2 (fr) 2004-12-11 2005-12-12 Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes
US76217206P 2006-01-25 2006-01-25
US60/762,172 2006-01-25

Publications (2)

Publication Number Publication Date
WO2007018744A2 true WO2007018744A2 (fr) 2007-02-15
WO2007018744A3 WO2007018744A3 (fr) 2008-07-03

Family

ID=37728257

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/023439 WO2007018744A2 (fr) 2005-08-03 2006-06-14 Biosynthese sans cellule d'acide nucleique

Country Status (1)

Country Link
WO (1) WO2007018744A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005365A1 (fr) * 2008-07-09 2010-01-14 General Electric Company Produit d'amplification par cercle roulant non traité
US8921072B2 (en) 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
US9125845B2 (en) 2008-07-09 2015-09-08 General Electric Company DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
US11324839B2 (en) 2019-09-18 2022-05-10 Intergalactic Therapeutics, Inc. b Synthetic DNA vectors and methods of use

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190608A1 (en) * 1999-11-12 2003-10-09 Gary Blackburn Microfluidic devices comprising biochannels
WO2005003389A2 (fr) * 2003-06-28 2005-01-13 Royal Holloway And Bedford New College Amplification in vitro de l'adn
WO2006063355A2 (fr) * 2004-12-11 2006-06-15 Cytogenix , Inc. Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030190608A1 (en) * 1999-11-12 2003-10-09 Gary Blackburn Microfluidic devices comprising biochannels
WO2005003389A2 (fr) * 2003-06-28 2005-01-13 Royal Holloway And Bedford New College Amplification in vitro de l'adn
WO2006063355A2 (fr) * 2004-12-11 2006-06-15 Cytogenix , Inc. Biosynthese acellulaire d'acide nucleique de haute qualite et utilisations correspondantes

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CAMPÀS ET AL: "DNA biochip arraying, detection and amplification strategies" TRENDS IN ANALYTICAL CHEMISTRY, vol. 23, January 2004 (2004-01), pages 49-62, XP004484688 *
DEAN ET AL: "Rapid amplification of plasmid and phage DNA using Phi29 DNA polymerase and multiply-primed rolling circle amplification" GENOME RESEARCH, vol. 11, 2001, pages 1095-1099, XP002261245 cited in the application *
DEMIDOV: "10 years of rolling the minicircles: RCA assays in DNA diagnostics" EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, vol. 5, July 2005 (2005-07), pages 477-478, XP009074526 *
LUTHRA ET AL: "Isothermal multiple displacement amplification. A highly reliable approach for generating unlimited high molecular weight genomic DNA from clinical specimens" JOURNAL OF MOLECULAR DIAGNOSTICS, vol. 6, August 2004 (2004-08), pages 236-242, XP002371240 *
RECTOR ET AL: "A sequence-independent strategy for detection and cloning of circular DNA virus genomes by using multiply primed rolling-circle amplification" JOURNAL OF VIROLOGY, vol. 78, May 2004 (2004-05), pages 4993-4998, XP002392144 *
WANG ET AL: "DNA amplification method tolerant to sample degradation" GENOME RESEARCH, vol. 14, November 2004 (2004-11), pages 2357-2366, XP002391762 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010005365A1 (fr) * 2008-07-09 2010-01-14 General Electric Company Produit d'amplification par cercle roulant non traité
JP2011527570A (ja) * 2008-07-09 2011-11-04 ゼネラル・エレクトリック・カンパニイ 未処理ｒｃａ産物
US9125845B2 (en) 2008-07-09 2015-09-08 General Electric Company DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
US8921072B2 (en) 2008-09-02 2014-12-30 General Electric Compnay Methods to generate DNA mini-circles
US11324839B2 (en) 2019-09-18 2022-05-10 Intergalactic Therapeutics, Inc. b Synthetic DNA vectors and methods of use
US11602569B2 (en) 2019-09-18 2023-03-14 Intergalactic Therapeutics, Inc. Synthetic DNA vectors and methods of use
US11684680B2 (en) 2019-09-18 2023-06-27 Intergalactic Therapeutics, Inc. Synthetic DNA vectors and methods of use
US11766490B2 (en) 2019-09-18 2023-09-26 Intergalactic Therapeutics, Inc. Synthetic DNA vectors and methods of use

Also Published As

Publication number Publication date
WO2007018744A3 (fr) 2008-07-03

Similar Documents

Publication Publication Date Title
AU2005314431B2 (en) Cell free biosynthesis of high-quality nucleic acid and uses thereof
Rosa et al. mRNA vaccines manufacturing: Challenges and bottlenecks
US20220127667A1 (en) Method of dna synthesis
Mayrhofer et al. Use of minicircle plasmids for gene therapy
JP6689726B2 (ja) パリンドローム配列を用いた閉鎖型直鎖状ｄｎａの生成
EP4233898A2 (fr) Vaccins contre l'arnm de la grippe
JP2023024506A5 (fr)
JP2016047049A (ja) 閉鎖型直鎖状ｄｎａの製造
CA3216490A1 (fr) Vaccins a arnm du virus d'epstein-barr
EP2307575B1 (fr) Produit d'amplification par cercle roulant non traité
WO2007018744A2 (fr) Biosynthese sans cellule d'acide nucleique
WO1998001540A1 (fr) Procede de production d'adn therapeutique
US10350307B2 (en) In vivo RNA or protein expression using double-stranded concatemeric DNA including phosphorothioated nucleotides
CA3167380A1 (fr) Arnm modifies pour le developpement de vaccins
CN101103122A (zh) 高质量核酸的无细胞生物合成及其用途
US9125845B2 (en) DNA vaccines, uses for unprocessed rolling circle amplification product and methods for making the same
US20060183703A1 (en) Circular expression construct for gene therapeutic applications
Voß Production of plasmid DNA for pharmaceutical use
WO2020193610A1 (fr) Procédé et produits de production de molécules d'arn
EP3964576A1 (fr) Arnm modifiés pour le développement de vaccins
JP2023518734A (ja) インビトロトランスクリプトｍｒｎａ及びこれを含有する薬学組成物
CN117916387A (zh) 用于rna亲和纯化的组合物和方法
JP2023073997A (ja) 循環ｒｎａプラットフォーム、その用途、および操作されたｄｎａからの製造プロセス
KR20230127069A (ko) 세포질에서 자가 전사가 가능한 mRNA를 제공하는 RNA/DNA 시스템
WO2021038089A1 (fr) Arn messagers minimaux et leurs utilisations

Legal Events

Date Code Title Description
NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06773321

Country of ref document: EP

Kind code of ref document: A2